Serum triglyceride and total cholesterol levels were measured (
FUJI DRI-CHEM; Fujifilm, Tokyo, Japan). Urinary glucose levels were measured using a
blood glucose meter (Abbott, Japan). Urinary creatinine levels were measured using a
LabAssay Creatinine Kit (Fujifilm Wako Pure Chemical Corporation, Osaka, Japan). Urinary protein levels were measured using a
Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). The insulin in the serum and the liver-type fatty acid-binding protein (L-FABP) in the urine and serum were measured in duplicate using a commercially available enzyme-linked immunoassay kit (#10-1247-01; Mercodia AB, Uppsala, Sweden, and RFBP10; R&D system, Minneapolis, MN, USA).
Saitoh S., Takaki T., Nakajima K., Wo B., Terashima H., Shimo S., Nguyen H.B., Thai T.Q., Kumamoto K., Kunisawa K., Nagao S., Tojo A., Ohno N, & Takahashi K. (2023). Treatment of tubular damage in high-fat-diet-fed obese mice using sodium-glucose co-transporter inhibitors. PLOS ONE, 18(2), e0281770.